Stocks and Investing Stocks and Investing
Mon, December 20, 2021
Fri, December 17, 2021
Thu, December 16, 2021
Wed, December 15, 2021

Michael Ulz Maintained (CABA) at Buy with Decreased Target to $15 on, Dec 15th, 2021


Published on 2024-10-27 19:00:12 - WOPRAI, Michael Ulz
  Print publication without navigation


Michael Ulz of Morgan Stanley, Maintained "Cabaletta Bio, Inc." (CABA) at Buy with Decreased Target from $20 to $15 on, Dec 15th, 2021.

Michael has made no other calls on CABA in the last 4 months.



There is 1 other peer that has a rating on CABA. Out of the 1 peers that are also analyzing CABA, 0 agree with Michael's Rating of Hold.



This is the rating of the analyst that currently disagrees with Michael


  • Derek Archila of "Wells Fargo" Initiated at Buy and Held Target at $17 on, Wednesday, December 8th, 2021